Difference between revisions of "WSI24-422-Case-2"

From MGH Learn Pathology
Line 28: Line 28:
 
|frames=2
 
|frames=2
 
|status=completed
 
|status=completed
 +
|reasonCode=H&E
 
|view=show
 
|view=show
 
|identifier=568afacc-3613-4418-a460-a0f5731a1a55
 
|identifier=568afacc-3613-4418-a460-a0f5731a1a55
Line 36: Line 37:
 
|frames=5
 
|frames=5
 
|status=completed
 
|status=completed
 +
|reasonCode=HER2 IHC
 
|view=show
 
|view=show
 
|identifier=1b90423d-bfe5-414e-af19-635075d1f1b1
 
|identifier=1b90423d-bfe5-414e-af19-635075d1f1b1

Revision as of 14:00, February 3, 2026

WSI24-422-Case-2
43 yo F with invasive ductal carcinoma
HERs IHC: 2+ (OSH: 3+)

HER2 FISH: Amplified

Ratio = 4.6, 6.8/1.5, Group 1
February 6, 2026 2:00:00 PM